Stock Strategist Recommends Five Shares to Consider for Investment on 26 February 2026

Market Review: February 25, 2024

Key Figures:

• Sensex: 82,276.07, up 50 points (0.06%)
• Nifty 50: 25,482.50, up 58 points (0.23%)

Market Analysis:

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The Indian stock market witnessed a cautious recovery on Wednesday, February 25, 2024, driven by upbeat global cues. The Sensex and Nifty 50 indices closed higher, with the Sensex ending at 82,276.07 and the Nifty 50 settling at 25,482.50.

Nifty 50 Outlook:

The Nifty 50 index attempted to stabilize near key short-term levels, with immediate support placed around 25,300-25,350 and resistance seen near 25,600-25,650. A sustained move above 25,600-25,650 is required to revive bullish momentum, while a breakdown below 25,300 could keep the short-term bias under pressure.

Bank Nifty Outlook:

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The Bank Nifty index traded in a sideways structure, reflecting consolidation near the 61,000 zone. Immediate support is seen near 60,700-60,800, while resistance is placed around 61,300-61,400. A decisive breakout above 61,550 could extend the move toward higher all-time levels, while sustained weakness below 60,600 may invite sharper selling pressure.

Stock Recommendations:

Based on technical analysis, Sumeet Bagadia, Executive Director at Choice Broking, recommends the following five stocks for a buy:

1. Vedanta: Buy at ₹727, Target ₹770, Stop Loss ₹706
2. Laurus Labs: Buy at ₹1076, Target ₹1141, Stop Loss ₹1030
3. Aurobindo Pharma: Buy at ₹1212, Target ₹1280, Stop Loss ₹1160
4. Mangalam Cement: Buy at ₹921, Target ₹1000, Stop Loss ₹885
5. Bank of Maharashtra: Buy at ₹74.08, Target ₹79, Stop Loss ₹71